BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31879358)

  • 1. TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development.
    Cornelissen LM; Drenth AP; van der Burg E; de Bruijn R; Pritchard CEJ; Huijbers IJ; Zwart W; Jonkers J
    Genes Dev; 2020 Feb; 34(3-4):179-193. PubMed ID: 31879358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPS1 drives heterochromatic origin refiring and cancer genome evolution.
    Yang J; Liu X; Huang Y; He L; Zhang W; Ren J; Wang Y; Wu J; Wu X; Shan L; Yang X; Sun L; Liang J; Zhang Y; Shang Y
    Cell Rep; 2021 Mar; 34(10):108814. PubMed ID: 33691114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
    Witwicki RM; Ekram MB; Qiu X; Janiszewska M; Shu S; Kwon M; Trinh A; Frias E; Ramadan N; Hoffman G; Yu K; Xie Y; McAllister G; McDonald R; Golji J; Schlabach M; deWeck A; Keen N; Chan HM; Ruddy D; Rejtar T; Sovath S; Silver S; Sellers WR; Jagani Z; Hogarty MD; Roberts C; Brown M; Stegmaier K; Long H; Shivdasani RA; Pellman D; Polyak K
    Cell Rep; 2018 Oct; 25(5):1255-1267.e5. PubMed ID: 30380416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.
    Fujita N; Jaye DL; Kajita M; Geigerman C; Moreno CS; Wade PA
    Cell; 2003 Apr; 113(2):207-19. PubMed ID: 12705869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPS1 maintains luminal progenitors in the mammary gland by repressing SRF/MRTF activity.
    Tollot-Wegner M; Jessen M; Kim K; Sanz-Moreno A; Spielmann N; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; von Eyss B
    Breast Cancer Res; 2024 May; 26(1):74. PubMed ID: 38702730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
    Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
    Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
    Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
    Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
    Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
    Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin.
    Schipper K; Seinstra D; Paulien Drenth A; van der Burg E; Ramovs V; Sonnenberg A; van Rheenen J; Nethe M; Jonkers J
    Nat Commun; 2019 Aug; 10(1):3800. PubMed ID: 31444332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
    Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
    Schipper K; Drenth AP; van der Burg E; Cornelissen S; Klarenbeek S; Nethe M; Jonkers J
    Cancer Res; 2020 Apr; 80(7):1486-1497. PubMed ID: 32060147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.
    Serandour AA; Mohammed H; Miremadi A; Mulder KW; Carroll JS
    Oncogene; 2018 Sep; 37(39):5281-5291. PubMed ID: 29895970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
    Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
    Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland.
    Onoyama I; Nakayama S; Shimizu H; Nakayama KI
    Cancer Res; 2020 Dec; 80(24):5515-5530. PubMed ID: 33234509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
    Derksen PW; Braumuller TM; van der Burg E; Hornsveld M; Mesman E; Wesseling J; Krimpenfort P; Jonkers J
    Dis Model Mech; 2011 May; 4(3):347-58. PubMed ID: 21282721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
    Idoux-Gillet Y; Nassour M; Lakis E; Bonini F; Theillet C; Du Manoir S; Savagner P
    Oncogene; 2018 Feb; 37(5):578-588. PubMed ID: 28991231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.